Compare EUDA & MDAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | EUDA | MDAI |
|---|---|---|
| Founded | 2021 | 2013 |
| Country | Singapore | United States |
| Employees | N/A | N/A |
| Industry | Blank Checks | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 52.8M | 51.5M |
| IPO Year | 2021 | 2021 |
| Metric | EUDA | MDAI |
|---|---|---|
| Price | $12.78 | $1.44 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $4.00 |
| AVG Volume (30 Days) | 30.6K | ★ 106.9K |
| Earning Date | 12-19-2023 | 11-10-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 65.88 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $19,650,000.00 |
| Revenue This Year | $299.28 | N/A |
| Revenue Next Year | N/A | $74.98 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.33 | $1.18 |
| 52 Week High | $25.70 | $2.97 |
| Indicator | EUDA | MDAI |
|---|---|---|
| Relative Strength Index (RSI) | 39.67 | 29.73 |
| Support Level | $12.39 | $1.37 |
| Resistance Level | $16.18 | $1.48 |
| Average True Range (ATR) | 1.56 | 0.06 |
| MACD | -0.46 | -0.02 |
| Stochastic Oscillator | 12.89 | 1.35 |
EUDA Health Holdings Ltd is a Singapore-based non-invasive healthcare provider in Asia with a focus on Singapore, Malaysia, and China. It offers inventive, accessible, and science-based health solutions to support the shift in regional healthcare from reactive medical treatment to proactive, longevity-focused care. The group also runs a Singapore-based property management business. It operates in two reportable segments: property management services and holistic wellness consumer products and services. Key revenue is generated from property management services that include management and security services for properties such as condominiums, residential apartments, business office buildings, and shopping malls.
Spectral AI Inc is an AI company focused on predictive medical diagnostics. Its DeepView System uses proprietary AI algorithms to distinguish between fully damaged, partially damaged and healthy human tissue characters invisible to the naked eye, at the initial time point of wound presentation. The DeepView System delivers a binary prediction on the wound's capacity to heal or not-heal by a specified time point in the future. The company focuses on the burn indication which is supported by the BARDA PBS contract.